Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
MedTech
Labcorp launches new hepatitis D test
Labcorp is looking to plug the gap in hepatitis D monitoring with a testing solution to help find more patients with this form of the virus earlier.
Ben Adams
Aug 25, 2026 1:22pm
Atea’s hepatitis C asset matches Gilead’s Epclusa in phase 3
Jul 28, 2026 9:08am
Study reveals genetic red flags for CAR-T therapy side effects
Jul 24, 2026 2:00pm
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO
Jun 24, 2026 3:03pm
ASCO: BMS' bispecific ADC puts TROP2 drugs on notice
Jun 2, 2026 8:00am
ASCO: RevMed confident in RAS leadership as rivals square up
May 31, 2026 8:00am
